Trial guide

Your guide to clinical trials

What a trial is, how the phases differ, who can join, what consent means and how your safety is watched. Read it in order, or jump to the part you need.

What a clinical trial is

A clinical trial is a research study in people that answers a question about health: whether a new medicine works, whether one treatment is better than another, or whether a test can find a disease sooner. Every medicine at your pharmacy was studied this way before it was approved.

Trials follow a written plan, called a protocol, that sets out who can take part, what happens at each visit and how results are measured. An independent ethics board reviews the plan before anyone joins.

Why people take part

Some people join to try a treatment that is not yet available elsewhere. Others want closer checkups, or want to help people who will have the same condition later. Many have more than one reason.

There are also reasons to say no: the time involved, travel, side effects, or simply not wanting to. Saying no never affects the care you receive from your own doctor.

The phases of a trial

Phase 1 is small and looks mainly at safety and dose. Phase 2 is larger and starts to show whether a treatment works. Phase 3 compares the treatment with the usual one, often across many sites. Phase 4 continues after approval, watching how the treatment does in everyday use.

Not every study has a phase. Studies that only observe, collect samples or test a device or a way of giving care often do not.

Phase 1Small studies on safety and dose.
Phase 2Larger, and first signs of benefit.
Phase 3Compared with usual care, often at many sites.
Phase 4Continued study after approval.

Who can join

Each trial lists the people it needs. These lists cover things like age, the type and stage of a condition, past treatment, other health problems and current medicines. They exist to protect volunteers and to make the results clear.

Only the study team can decide whether you fit. A screening visit checks the details, and it is normal to hear no. A no from one study says nothing about the next.

Placebos and comparisons

Some trials compare a new treatment with a placebo, which looks the same but contains no active medicine. In serious illness, a placebo is usually added to standard treatment rather than given instead of it.

Many trials compare the new treatment with the one doctors already use. Often neither you nor the team knows which group you are in until the study ends. The consent form says plainly whether a placebo is used.

How your safety is watched

Study teams check on you at every visit and record every side effect, however small. An independent group often reviews the results while the study runs and can stop it early if there is a safety concern.

If something worries you between visits, call the study team on the number they give you. In an emergency, call 911 first.

Time, travel and costs

The consent form explains which tests and treatments the study pays for, and which are billed to your insurance as part of usual care. Some studies help with travel, parking or meals. Ask before you agree, since this differs between studies.

Ask too how long each visit takes and how many there are. A study that fits your week is a study you can finish.

Leaving a study

You can leave at any time, for any reason, without explaining. The team may ask you back for a final safety check, and your usual care carries on as before.

Research updates

Stay updated on research in your area

Pick the area you follow and Verixmed will send an occasional update by email, and by text if you choose. It costs nothing, and one reply stops the texts.

Get research updates
  • Free to receive
  • Texts are optional